{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:00:11Z","timestamp":1793505611088,"version":"4.5.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-1172-9-71","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T22:32:14Z","timestamp":1399329134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects"],"prefix":"10.1186","volume":"9","author":[{"given":"Afshin","family":"Amini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Masoumi-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Ehteda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Lawson","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,5]]},"reference":[{"key":"746_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA: Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008, 34: 196-201. 10.1016\/j.ejso.2007.04.002.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR2","unstructured":"The portal for rare diseases and orphan drugs. [http:\/\/www.orpha.net\/consor\/cgi-bin\/index.php?lng=EN]"},{"key":"746_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF01837425","volume":"24","author":"R Werth","year":"1884","unstructured":"Werth R: Klinische und anatomische untersuchungen zur lehre von den bauchgeschw\u00fclsten und der laparatomie. Archiv Fur Gynakologie. 1884, 24: 100-118. 10.1007\/BF01837425.","journal-title":"Archiv Fur Gynakologie"},{"key":"746_CR4","first-page":"965","volume":"48","author":"E Fraenkel","year":"1901","unstructured":"Fraenkel E: Ueber das sogennante pseudomyxoma perotonei. Munch Med Wochenschr. 1901, 48: 965-971.","journal-title":"Munch Med Wochenschr"},{"key":"746_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d. Am J Surg Pathol. 1995, 19: 1390-1408. 10.1097\/00000478-199512000-00006.","journal-title":"Am J Surg Pathol"},{"key":"746_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4613-1245-1_10","volume":"81","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH: Pseudomyxoma peritonei. Cancer Treat Res. 1996, 81: 105-119. 10.1007\/978-1-4613-1245-1_10.","journal-title":"Cancer Treat Res"},{"key":"746_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001, 92: 85-91. 10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R.","journal-title":"Cancer"},{"key":"746_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","volume":"161","author":"JT O\u2019Connell","year":"2002","unstructured":"O\u2019Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH: Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol. 2002, 161: 551-564. 10.1016\/S0002-9440(10)64211-3.","journal-title":"Am J Pathol"},{"key":"746_CR9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5858\/134.6.864","volume":"134","author":"J Misdraji","year":"2010","unstructured":"Misdraji J: Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med. 2010, 134: 864-870.","journal-title":"Arch Pathol Lab Med"},{"key":"746_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14694\/EdBook_AM.2013.33.221","volume":"33","author":"R Buell-Gutbrod","year":"2013","unstructured":"Buell-Gutbrod R, Gwin K: Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei. Am Soc Clin Oncol Educ Book. 2013, 33: 221-225.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"746_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","volume":"219","author":"PH Sugarbaker","year":"1994","unstructured":"Sugarbaker PH: Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994, 219: 109-111. 10.1097\/00000658-199402000-00001.","journal-title":"Ann Surg"},{"key":"746_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol. 2006, 7: 69-76. 10.1016\/S1470-2045(05)70539-8.","journal-title":"Lancet Oncol"},{"key":"746_CR13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1245\/s10434-013-3261-6","volume":"21","author":"K Lohani","year":"2014","unstructured":"Lohani K, Shetty S, Sharma P, Govindarajan V, Thomas P, Loggie B: Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal Microenvironment. Ann Surg Oncol. 2014, 21: 1441-1447. 10.1245\/s10434-013-3261-6.","journal-title":"Ann Surg Oncol"},{"key":"746_CR14","unstructured":"Pseudomyxoma peritonei. [http:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=EN&Expert=26790]"},{"key":"746_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, G\u00f3mez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonz\u00e1lez-Moreno S, Van Der Speeten K, Morris DL: Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012, 30: 2449-2456. 10.1200\/JCO.2011.39.7166.","journal-title":"J Clin Oncol"},{"key":"746_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1067\/j.cpsurg.2008.04.003","volume":"45","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ: Pseudomyxoma peritonei. Curr Probl Surg. 2008, 45: 527-575. 10.1067\/j.cpsurg.2008.04.003.","journal-title":"Curr Probl Surg"},{"key":"746_CR17","first-page":"233","volume":"30","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, Dalton RR, Ettinghausen SE, Jacquet P, Jelinek J, Koslowe P, Kurman RJ, Shmookler B, Stephens AD, Steves MA, Stuart OA, White S, Zahn CM, Zoetmulder FA: Pseudomyxoma peritonei syndrome. Adv Surg. 1996, 30: 233-280.","journal-title":"Adv Surg"},{"key":"746_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1365-2168.2000.01553.x","volume":"87","author":"J Esquivel","year":"2000","unstructured":"Esquivel J, Sugarbaker PH: Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg. 2000, 87: 1414-1418. 10.1046\/j.1365-2168.2000.01553.x.","journal-title":"Br J Surg"},{"key":"746_CR19","first-page":"299","volume":"17","author":"H Ben-Hur","year":"1996","unstructured":"Ben-Hur H, Schachter M, Mashiah A, Lifschitz-Mercer B, Pfeffermann R: Recurrent mucinous adenocarcinoma of the ovary presenting as an inguino-labial hernia. Eur J Gynaecol Oncol. 1996, 17: 299-302.","journal-title":"Eur J Gynaecol Oncol"},{"key":"746_CR20","first-page":"1228","volume":"10","author":"RH Young","year":"1997","unstructured":"Young RH, Rosenberg AE, Clement PB: Mucin deposits within inguinal hernia sacs: a presenting finding of low-grade mucinous cystic tumors of the appendix. A report of two cases and a review of the literature. Mod Pathol. 1997, 10: 1228-1232.","journal-title":"Mod Pathol"},{"key":"746_CR21","first-page":"112","volume":"43","author":"DP Edwards","year":"1998","unstructured":"Edwards DP, Scott HJ: The use of laparoscopy in a case of appendiceal cystadenoma presenting as pseudomyxoma peritonei in an inguinal hernial sac. J R Coll Surg Edinb. 1998, 43: 112-113.","journal-title":"J R Coll Surg Edinb"},{"key":"746_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/ejso.2000.1031","volume":"27","author":"J Esquivel","year":"2001","unstructured":"Esquivel J, Sugarbaker PH: Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair. Eur J Surg Oncol. 2001, 27: 54-58. 10.1053\/ejso.2000.1031.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR23","first-page":"54","volume":"59","author":"MA Rezkalla","year":"2006","unstructured":"Rezkalla MA, Peterson KG, Ryan JJ: Pseudomyxoma peritonei: a case of mucinous adenocarcinoma of the appendix presenting as inguinal hernia. S D Med. 2006, 59: 54-55. 57","journal-title":"S D Med"},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s10147-006-0594-1","volume":"11","author":"T Shinohara","year":"2006","unstructured":"Shinohara T, Misawa K, Sano H, Okawa Y, Takada A: Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia. Int J Clin Oncol. 2006, 11: 416-419. 10.1007\/s10147-006-0594-1.","journal-title":"Int J Clin Oncol"},{"key":"746_CR25","first-page":"189","volume":"78","author":"P Campbell","year":"2009","unstructured":"Campbell P, Dawson S, Wali J, Kenny B, Whiteside MC: Pseudomyxoma peritonei presenting as inguinal hernia. Ulster Med J. 2009, 78: 189-190.","journal-title":"Ulster Med J"},{"key":"746_CR26","first-page":"527","volume":"106","author":"G Ghidirim","year":"2011","unstructured":"Ghidirim G, Mishin I, Zastavnitsky G: Pseudomyxoma peritonei presenting with inguinal hernia. Chirurgia (Bucur). 2011, 106: 527-529.","journal-title":"Chirurgia (Bucur)"},{"key":"746_CR27","volume-title":"BMJ case reports","author":"G Morris-Stiff","year":"2011","unstructured":"Morris-Stiff G, Falk GA, Joyce D, Chalikonda S: Unusual contents of a scrotal swelling. BMJ case reports. 2011, 2011: doi:10.1136\/bcr.03.2011.4023"},{"key":"746_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004728-198505000-00031","volume":"9","author":"P Skaane","year":"1985","unstructured":"Skaane P, Isachsen MM, Hoiseth A: Computed tomography of mucin-producing adenocarcinoma of the appendix presenting as a bladder tumor. Comput Assist Tomogr. 1985, 9: 566-567. 10.1097\/00004728-198505000-00031.","journal-title":"Comput Assist Tomogr"},{"key":"746_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12262-012-0408-9","volume":"74","author":"VV Gandhi","year":"2012","unstructured":"Gandhi VV, Nagral S: Pseudomyxoma peritonea: uncommon presentation. Indian J Surg. 2012, 74: 172-173. 10.1007\/s12262-012-0408-9.","journal-title":"Indian J Surg"},{"key":"746_CR30","first-page":"103","volume":"37","author":"TE Snyder","year":"1992","unstructured":"Snyder TE, Vandivort MR: Mucinous cystadenocarcinoma of the appendix with pseudomyxoma peritonei presenting as total uterine prolapse. A case report. J Reprod Med. 1992, 37: 103-106.","journal-title":"J Reprod Med"},{"key":"746_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10151-010-0654-4","volume":"15","author":"CM Newman","year":"2011","unstructured":"Newman CM, Moran BJ: Pseudomyxoma peritonei presenting as recurrent rectal cancer: a preventable condition?. Tech Coloproctol. 2011, 15: 89-90. 10.1007\/s10151-010-0654-4.","journal-title":"Tech Coloproctol"},{"key":"746_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1447-0756.2010.01379.x","volume":"37","author":"S Koyama","year":"2011","unstructured":"Koyama S, Tomimatsu T, Sawada K, Kanagawa T, Tsutsui T, Kimura T: Pseudomyxoma peritonei originating from colorectal cancer during pregnancy. J Obstet Gynaecol Res. 2011, 37: 254-258. 10.1111\/j.1447-0756.2010.01379.x.","journal-title":"J Obstet Gynaecol Res"},{"key":"746_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1055\/s-0029-1220791","volume":"26","author":"B Abdu","year":"2009","unstructured":"Abdu B, Hobgood D, Stallings S, Depasquale S: Incidental finding of pseudomyxoma peritonei at primary cesarean section. Am J Perinatol. 2009, 26: 633-635. 10.1055\/s-0029-1220791.","journal-title":"Am J Perinatol"},{"key":"746_CR34","first-page":"79","volume":"20","author":"A Cakmak","year":"2009","unstructured":"Cakmak A, Karakayali F, Bayar S, Unal E, Akyol C, Kocaoglu H: Pseudomyxoma retroperitonei presenting with a skin fistula. Turk J Gastroenterol. 2009, 20: 79-80.","journal-title":"Turk J Gastroenterol"},{"key":"746_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11845-008-0118-2","volume":"178","author":"N Srinivasaiah","year":"2009","unstructured":"Srinivasaiah N, Retnasingam G, Kasarneni R, Slater B: Pseudomyxoma peritonei: a rare presentation as an umbilical nodule. Ir J Med Sci. 2009, 178: 219-221. 10.1007\/s11845-008-0118-2.","journal-title":"Ir J Med Sci"},{"key":"746_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ctrv.2006.11.001","volume":"33","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Zoetmulder FA: Pseudomyxoma peritonei. Cancer Treat Rev. 2007, 33: 138-145. 10.1016\/j.ctrv.2006.11.001.","journal-title":"Cancer Treat Rev"},{"key":"746_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00404-004-0663-5","volume":"271","author":"E Kalu","year":"2005","unstructured":"Kalu E, Croucher C: Appendiceal mucocele: a rare differential diagnosis of a cystic right adnexal mass. Arch Gynecol Obstet. 2005, 271: 86-88. 10.1007\/s00404-004-0663-5.","journal-title":"Arch Gynecol Obstet"},{"key":"746_CR38","volume-title":"Obstet Gynecol Int","author":"G Gortchev","year":"2010","unstructured":"Gortchev G, Tomov S, Dimitrov D, Nanev V, Betova T: Appendiceal mucocele presenting as a right adnexal mass: a case report. Obstet Gynecol Int. 2010, 2010: doi:10.1155\/2010\/281053"},{"key":"746_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1046\/j.1469-0705.2002.00611.x","volume":"19","author":"S Khan","year":"2002","unstructured":"Khan S, Patel AG, Jurkovic D: Incidental ultrasound diagnosis of pseudomyxoma peritonei in an asymptomatic woman. Ultrasound Obstet Gynecol. 2002, 19: 410-412. 10.1046\/j.1469-0705.2002.00611.x.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"746_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0149-936X(80)80004-X","volume":"4","author":"L Kreel","year":"1980","unstructured":"Kreel L, Bydder GM: Computed tomography of fluid collections within the abdomen. J Comput Tomogr. 1980, 4: 105-115. 10.1016\/S0149-936X(80)80004-X.","journal-title":"J Comput Tomogr"},{"key":"746_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/crad.2002.0942","volume":"57","author":"TV Sulkin","year":"2002","unstructured":"Sulkin TV, O\u2019Neill H, Amin AI, Moran B: CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002, 57: 608-613. 10.1053\/crad.2002.0942.","journal-title":"Clin Radiol"},{"key":"746_CR42","first-page":"115","volume":"9","author":"JN Buy","year":"1989","unstructured":"Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J: Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol. 1989, 9: 115-118.","journal-title":"Eur J Radiol"},{"key":"746_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s003300050692","volume":"9","author":"Y Matsuoka","year":"1999","unstructured":"Matsuoka Y, Masumoto T, Suzuki K, Terada K, Ushimi T, Yokoyama Y, Abe K, Kamata N, Yasuno M, Hishima T: Pseudomyxoma retroperitonei. Eur Radiol. 1999, 9: 457-459. 10.1007\/s003300050692.","journal-title":"Eur Radiol"},{"key":"746_CR44","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0221-0363(08)73781-8","volume":"89","author":"A Fairise","year":"2008","unstructured":"Fairise A, Barbary C, Derelle A, Tissier S, Granger P, Marchal F, Laurent V: Regent D: [Mucocele of the appendix and pseudomyxoma peritonei]. J Radiol. 2008, 89: 751-762. 10.1016\/S0221-0363(08)73781-8.","journal-title":"J Radiol"},{"key":"746_CR45","first-page":"1817","volume":"33","author":"QM Yang","year":"2006","unstructured":"Yang QM, Bando E, Kawamura T, Tsukiyama G, Nemoto M, Yonemura Y, Furukawa H: The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. Gan To Kagaku Ryoho. 2006, 33: 1817-1821.","journal-title":"Gan To Kagaku Ryoho"},{"key":"746_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejso.2009.09.001","volume":"36","author":"G Passot","year":"2010","unstructured":"Passot G, Glehen O, Pellet O, Isaac S, Tychyj C, Mohamed F, Giammarile F, Gilly FN, Cotte E: Pseudomyxoma peritonei: role of 18\u00a0F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol. 2010, 36: 315-323. 10.1016\/j.ejso.2009.09.001.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1245\/ASO.2005.12.001","volume":"12","author":"JH Stewart IV","year":"2005","unstructured":"Stewart JH, Shen P, Levine EA: Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005, 12: 765-777. 10.1245\/ASO.2005.12.001.","journal-title":"Ann Surg Oncol"},{"key":"746_CR48","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/000313481007601217","volume":"76","author":"P Rohani","year":"2010","unstructured":"Rohani P, Scotti SD, Shen P, Stewart JH, Russell GB, Cromer M, Levine EA: Use of FDG-PET imaging for patients with disseminated cancer of the appendix. Am Surg. 2010, 76: 1338-1344.","journal-title":"Am Surg"},{"key":"746_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jso.20107","volume":"87","author":"CP Carmignani","year":"2004","unstructured":"Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH: Utility of CEA and CA 19\u20139 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol. 2004, 87: 162-166. 10.1002\/jso.20107.","journal-title":"J Surg Oncol"},{"key":"746_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1463-1318.2005.00773.x","volume":"7","author":"F Alexander-Sefre","year":"2005","unstructured":"Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B: Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis. 2005, 7: 382-386. 10.1111\/j.1463-1318.2005.00773.x.","journal-title":"Colorectal Dis"},{"key":"746_CR51","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1245\/ASO.2002.04.020","volume":"9","author":"S van Ruth","year":"2002","unstructured":"van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA: Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002, 9: 961-967. 10.1245\/ASO.2002.04.020.","journal-title":"Ann Surg Oncol"},{"key":"746_CR52","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M: Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2007, 14: 2300-2308. 10.1245\/s10434-007-9393-9.","journal-title":"Ann Surg Oncol"},{"key":"746_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","volume":"256","author":"TC Chua","year":"2012","unstructured":"Chua TC, Chong CH, Liauw W, Zhao J, Morris DL: Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg. 2012, 256: 342-349. 10.1097\/SLA.0b013e3182602ad2.","journal-title":"Ann Surg"},{"key":"746_CR54","first-page":"173","volume":"4","author":"JL Koh","year":"2013","unstructured":"Koh JL, Liauw W, Chua T, Morris DL: Carbohydrate antigen 19\u20139 (CA 19\u20139) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol. 2013, 4: 173-181.","journal-title":"J Gastrointest Oncol"},{"key":"746_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.23329","volume":"108","author":"S Kusamura","year":"2013","unstructured":"Kusamura S, Hutanu I, Baratti D, Deraco M: Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol. 2013, 108: 1-8. 10.1002\/jso.23329.","journal-title":"J Surg Oncol"},{"key":"746_CR56","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","volume":"15","author":"JT O\u2019Connell","year":"2002","unstructured":"O\u2019Connell JT, Hacker CM, Barsky SH: MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol. 2002, 15: 958-972. 10.1097\/01.MP.0000026617.52466.9F.","journal-title":"Mod Pathol"},{"key":"746_CR57","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/sj.bjc.6603398","volume":"95","author":"R Bibi","year":"2006","unstructured":"Bibi R, Pranesh N, Saunders MP, Wilson MS, O\u2019Dwyer ST, Stern PL, Renehan AG: A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer. 2006, 95: 1258-1264. 10.1038\/sj.bjc.6603398.","journal-title":"Br J Cancer"},{"key":"746_CR58","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1245\/s10434-007-9778-9","volume":"15","author":"C Semino-Mora","year":"2008","unstructured":"Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A: Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol. 2008, 15: 1414-1423. 10.1245\/s10434-007-9778-9.","journal-title":"Ann Surg Oncol"},{"key":"746_CR59","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.humpath.2009.12.013","volume":"41","author":"K Flatmark","year":"2010","unstructured":"Flatmark K, Davidson B, Kristian A, Stavnes HT, Forsund M, Reed W: Exploring the peritoneal surface malignancy phenotype\u2013a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol. 2010, 41: 1109-1119. 10.1016\/j.humpath.2009.12.013.","journal-title":"Hum Pathol"},{"key":"746_CR60","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3748\/wjg.v17.i30.3531","volume":"17","author":"AT Guo","year":"2011","unstructured":"Guo AT, Song X, Wei LX, Zhao P: Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry. World J Gastroenterol. 2011, 17: 3531-3537. 10.3748\/wjg.v17.i30.3531.","journal-title":"World J Gastroenterol"},{"key":"746_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","volume":"249","author":"D Baratti","year":"2009","unstructured":"Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M: Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2009, 249: 243-249. 10.1097\/SLA.0b013e31818eec64.","journal-title":"Ann Surg"},{"key":"746_CR62","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/00000478-199408000-00013","volume":"18","author":"PB Clement","year":"1994","unstructured":"Clement PB, Granai CO, Young RH, Scully RE: Endometriosis with myxoid change. A case simulating pseudomyxoma peritonei. Am J Surg Pathol. 1994, 18: 849-853. 10.1097\/00000478-199408000-00013.","journal-title":"Am J Surg Pathol"},{"key":"746_CR63","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/sur.2012.140","volume":"14","author":"RV Sugi Subramaniam","year":"2013","unstructured":"Sugi Subramaniam RV, Karthikeyan VS, Sistla SC, Ali SM, Sistla S, Ram D, Sudhagar R: Melioidosis presenting as pseudomyxoma peritonei: yet another pretense of the great mimicker: an unreported entity. Surg Infect (Larchmt). 2013, 14: 415-417. 10.1089\/sur.2012.140.","journal-title":"Surg Infect (Larchmt)"},{"key":"746_CR64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00004728-198907000-00034","volume":"13","author":"DR Mirich","year":"1989","unstructured":"Mirich DR, Gray RR, Grosman H: Abdominal plexiform neurofibromatosis simulating pseudomyxoma peritonei on computed tomography. J Comput Assist Tomogr. 1989, 13: 709-711. 10.1097\/00004728-198907000-00034.","journal-title":"J Comput Assist Tomogr"},{"key":"746_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","volume":"219","author":"DB Gough","year":"1994","unstructured":"Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O\u2019Brien PC, van Heerden JA: Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994, 219: 112-119. 10.1097\/00000658-199402000-00002.","journal-title":"Ann Surg"},{"key":"746_CR66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","volume":"241","author":"TJ Miner","year":"2005","unstructured":"Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG: Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005, 241: 300-308. 10.1097\/01.sla.0000152015.76731.1f.","journal-title":"Ann Surg"},{"key":"746_CR67","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1463-1318.2009.01947.x","volume":"12","author":"P Jarvinen","year":"2010","unstructured":"Jarvinen P, Jarvinen HJ, Lepisto A: Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis. 2010, 12: 868-872. 10.1111\/j.1463-1318.2009.01947.x.","journal-title":"Colorectal Dis"},{"key":"746_CR68","first-page":"75","volume":"561","author":"PH Sugarbaker","year":"1991","unstructured":"Sugarbaker PH: Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma. Eur J Surg Suppl = Acta chirurgica Supplement. 1991, 561: 75-82.","journal-title":"Eur J Surg Suppl = Acta chirurgica Supplement"},{"key":"746_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/ejso.2000.1038","volume":"27","author":"PH Sugarbaker","year":"2001","unstructured":"Sugarbaker PH: Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001, 27: 239-243. 10.1053\/ejso.2000.1038.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR70","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1445-2197.2006.03579.x","volume":"76","author":"R Hadi","year":"2006","unstructured":"Hadi R, Saunders V, Utkina O, Clingan P, Kam P, Links M, Morris DL: Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg. 2006, 76: 156-161. 10.1111\/j.1445-2197.2006.03579.x.","journal-title":"ANZ J Surg"},{"key":"746_CR71","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/bjs.5427","volume":"93","author":"TD Yan","year":"2006","unstructured":"Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg. 2006, 93: 1270-1276. 10.1002\/bjs.5427.","journal-title":"Br J Surg"},{"key":"746_CR72","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","volume":"16","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL: Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10\u00a0years of experience from a single institution. Ann Surg Oncol. 2009, 16: 1903-1911. 10.1245\/s10434-009-0341-8.","journal-title":"Ann Surg Oncol"},{"key":"746_CR73","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1445-2197.2009.04940.x","volume":"79","author":"TC Chua","year":"2009","unstructured":"Chua TC, Liauw W, Morris DL: The St George Hospital peritoneal surface malignancy program\u2013where are we now?. ANZ J Surg. 2009, 79: 416-418.","journal-title":"ANZ J Surg"},{"key":"746_CR74","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1245\/s10434-009-0875-9","volume":"17","author":"A Saxena","year":"2010","unstructured":"Saxena A, Yan TD, Chua TC, Morris DL: Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2010, 17: 1291-1301. 10.1245\/s10434-009-0875-9.","journal-title":"Ann Surg Oncol"},{"key":"746_CR75","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/COC.0b013e3181b9cf47","volume":"33","author":"TC Chua","year":"2010","unstructured":"Chua TC, Baker B, Yan TD, Zhao J, Morris DL: Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy. Am J Clin Oncol. 2010, 33: 568-571. 10.1097\/COC.0b013e3181b9cf47.","journal-title":"Am J Clin Oncol"},{"key":"746_CR76","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jamcollsurg.2010.06.011","volume":"211","author":"TC Chua","year":"2010","unstructured":"Chua TC, Al-Zahrani A, Saxena A, Liauw W, Zhao J, Morris DL: Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation. J Am Coll Surg. 2010, 211: 526-535. 10.1016\/j.jamcollsurg.2010.06.011.","journal-title":"J Am Coll Surg"},{"key":"746_CR77","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/SLA.0b013e3181c9b53c","volume":"251","author":"TC Chua","year":"2010","unstructured":"Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL: Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg. 2010, 251: 323-329. 10.1097\/SLA.0b013e3181c9b53c.","journal-title":"Ann Surg"},{"key":"746_CR78","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1245\/s10434-010-1492-3","volume":"18","author":"TC Chua","year":"2011","unstructured":"Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL: Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2011, 18: 1582-1589. 10.1245\/s10434-010-1492-3.","journal-title":"Ann Surg Oncol"},{"key":"746_CR79","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/SLA.0b013e31820b4dba","volume":"253","author":"TC Chua","year":"2011","unstructured":"Chua TC, Liauw W, Zhao J, Morris DL: Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Ann Surg. 2011, 253: 769-773. 10.1097\/SLA.0b013e31820b4dba.","journal-title":"Ann Surg"},{"key":"746_CR80","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","volume":"27","author":"TC Chua","year":"2012","unstructured":"Chua TC, Liauw W, Morris DL: Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis. 2012, 27: 381-389. 10.1007\/s00384-011-1303-8.","journal-title":"Int J Colorectal Dis"},{"key":"746_CR81","first-page":"461041","volume":"2013","author":"R Kirby","year":"2013","unstructured":"Kirby R, Liauw W, Zhao J, Morris D: Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures. Int J Surg Oncol. 2013, 2013: 461041.","journal-title":"Int J Surg Oncol"},{"key":"746_CR82","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999, 6: 727-731. 10.1007\/s10434-999-0727-7.","journal-title":"Ann Surg Oncol"},{"key":"746_CR83","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1245\/ASO.2004.07.002","volume":"11","author":"M Deraco","year":"2004","unstructured":"Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S: Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004, 11: 393-398. 10.1245\/ASO.2004.07.002.","journal-title":"Ann Surg Oncol"},{"key":"746_CR84","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s10350-005-0045-5","volume":"48","author":"R Loungnarath","year":"2005","unstructured":"Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O: Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005, 48: 1372-1379. 10.1007\/s10350-005-0045-5.","journal-title":"Dis Colon Rectum"},{"key":"746_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10350-006-0741-9","volume":"50","author":"EM Murphy","year":"2007","unstructured":"Murphy EM, Sexton R, Moran BJ: Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007, 50: 37-42. 10.1007\/s10350-006-0741-9.","journal-title":"Dis Colon Rectum"},{"key":"746_CR86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007, 245: 104-109. 10.1097\/01.sla.0000231705.40081.1a.","journal-title":"Ann Surg"},{"key":"746_CR87","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jso.21054","volume":"98","author":"B Moran","year":"2008","unstructured":"Moran B, Baratti D, Yan TD, Kusamura S, Deraco M: Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008, 98: 277-282. 10.1002\/jso.21054.","journal-title":"J Surg Oncol"},{"key":"746_CR88","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F, Bereder JM, Sideris L, Mansvelt B, Lorimier G, Glehen O: Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010, 36: 456-462. 10.1016\/j.ejso.2010.01.006.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR89","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ejso.2012.07.009","volume":"38","author":"H Andreasson","year":"2012","unstructured":"Andreasson H, Graf W, Nygren P, Glimelius B, Mahteme H: Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Eur J Surg Oncol. 2012, 38: 962-968. 10.1016\/j.ejso.2012.07.009.","journal-title":"Eur J Surg Oncol"},{"key":"746_CR90","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","volume":"56","author":"S Dayal","year":"2013","unstructured":"Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ: Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum. 2013, 56: 1366-1372. 10.1097\/DCR.0b013e3182a62b0d.","journal-title":"Dis Colon Rectum"},{"key":"746_CR91","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AM Kuijpers","year":"2013","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Bremers AJ, de Wilt JH, Te Velde EA, Verwaal VJ: Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013, 20: 4224-4230. 10.1245\/s10434-013-3145-9.","journal-title":"Ann Surg Oncol"},{"key":"746_CR92","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jss.2012.12.040","volume":"183","author":"K McBride","year":"2013","unstructured":"McBride K, McFadden D, Osler T: Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res. 2013, 183: 246-252. 10.1016\/j.jss.2012.12.040.","journal-title":"J Surg Res"},{"key":"746_CR93","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/lap.1999.9.299","volume":"9","author":"J Raj","year":"1999","unstructured":"Raj J, Urban LM, ReMine SG, Raj PK: Laparoscopic management of pseudomyxoma peritonei secondary to adenocarcinoma of the appendix. J Laparoendosc Adv Surg Tech A. 1999, 9: 299-303. 10.1089\/lap.1999.9.299.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"746_CR94","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00464-013-3189-8","volume":"28","author":"R Fish","year":"2014","unstructured":"Fish R, Selvasekar C, Crichton P, Wilson M, Fulford P, Renehan A, O\u2019Dwyer S: Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique. Surg Endosc. 2014, 28: 341-345. 10.1007\/s00464-013-3189-8.","journal-title":"Surg Endosc"},{"key":"746_CR95","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00066-013-0470-7","volume":"190","author":"P Berkovic","year":"2014","unstructured":"Berkovic P, van de Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, Vandecasteele K: Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei. Strahlenther Onkolo: Organ der Deutschen Rontgengesellschaft [et al.]. 2014, 190: 223-228. 10.1007\/s00066-013-0470-7.","journal-title":"Strahlenther Onkolo: Organ der Deutschen Rontgengesellschaft [et al.]"},{"key":"746_CR96","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/1097-0142(197511)36:5<1834::AID-CNCR2820360539>3.0.CO;2-6","volume":"36","author":"N Green","year":"1975","unstructured":"Green N, Gancedo H, Smith R, Bernett G: Pseudomyxoma peritonei-nonoperative management and biochemical findings. A case report. Cancer. 1975, 36: 1834-1837. 10.1002\/1097-0142(197511)36:5<1834::AID-CNCR2820360539>3.0.CO;2-6.","journal-title":"Cancer"},{"key":"746_CR97","doi-asserted-by":"publisher","first-page":"95S","DOI":"10.1097\/00006250-198409001-00025","volume":"64","author":"MS Piver","year":"1984","unstructured":"Piver MS, Lele SB, Patsner B: Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol. 1984, 64: 95S-96S. 10.1097\/00006250-198409001-00025.","journal-title":"Obstet Gynecol"},{"key":"746_CR98","first-page":"301","volume":"48","author":"MA Machado","year":"1993","unstructured":"Machado MA, Rodrigues JG, Laurino RM, Garrido Junior A, Pinotti HW: [Conservative treatment of pseudomyxoma peritonei]. Rev Hosp Clin Fac Med Sao Paulo. 1993, 48: 301-304.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"746_CR99","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.jss.2011.10.038","volume":"174","author":"K Pillai","year":"2012","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL: Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei. J Surg Res. 2012, 174: e69-73. 10.1016\/j.jss.2011.10.038.","journal-title":"J Surg Res"},{"key":"746_CR100","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s10637-012-9797-7","volume":"30","author":"K Pillai","year":"2012","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL: Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei. Invest New Drugs. 2012, 30: 2080-2086. 10.1007\/s10637-012-9797-7.","journal-title":"Invest New Drugs"},{"key":"746_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1750-1172-8-105","volume":"8","author":"JJ Gilbreath","year":"2013","unstructured":"Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS: A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis. 2013, 8: 105-10.1186\/1750-1172-8-105.","journal-title":"Orphanet J Rare Dis"},{"key":"746_CR102","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1158\/1078-0432.CCR-13-0616","volume":"19","author":"C Semino-Mora","year":"2013","unstructured":"Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, Merrell DS, Dubois A: Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects beta-catenin distribution. Clin Cancer Res. 2013, 19: 3966-3976. 10.1158\/1078-0432.CCR-13-0616.","journal-title":"Clin Cancer Res"},{"key":"746_CR103","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1245\/s10434-012-2242-5","volume":"19","author":"HA Choudry","year":"2012","unstructured":"Choudry HA, Mavanur A, O\u2019Malley ME, Zeh HJ, Guo Z, Bartlett DL: Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei. Ann Surg Oncol. 2012, 19: 1402-1409. 10.1245\/s10434-012-2242-5.","journal-title":"Ann Surg Oncol"},{"key":"746_CR104","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/000313481307901120","volume":"79","author":"S Shetty","year":"2013","unstructured":"Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B: Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg. 2013, 79: 1171-1176.","journal-title":"Am Surg"},{"key":"746_CR105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7819-2-19","volume":"2","author":"MH Solkar","year":"2004","unstructured":"Solkar MH, Akhtar NM, Khan Z, Parker MC: Pseudomyxoma extraperitonei occurring 35\u00a0years after appendicectomy: a case report and review of literature. World J Surg Oncol. 2004, 2:19. 10.1186\/1477-7819-2-19.","journal-title":"World J Surg Oncol"},{"key":"746_CR106","doi-asserted-by":"publisher","first-page":"W33","DOI":"10.7326\/0003-4819-140-1-200401060-00009","volume":"140","author":"MA Thompson","year":"2004","unstructured":"Thompson MA, Ashton RW, Pitot HC: Mucinous appendiceal adenocarcinoma presenting 5\u00a0years after appendectomy. Ann Intern Med. 2004, 140: W33-10.7326\/0003-4819-140-1-200401060-00009.","journal-title":"Ann Intern Med"},{"key":"746_CR107","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-2005-836390","volume":"130","author":"J Vana","year":"2005","unstructured":"Vana J, Adamicova K, Johanes R, Zacharova O, Ammerova E, Solek R: [Appendiceal mucocele causing pseudomyxoma peritonei]. Zentralblatt fur Chirurgie. 2005, 130: 177-180. 10.1055\/s-2005-836390.","journal-title":"Zentralblatt fur Chirurgie"},{"key":"746_CR108","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00268-006-0454-1","volume":"31","author":"J Ruiz-Tovar","year":"2007","unstructured":"Ruiz-Tovar J, Teruel DG, Castineiras VM, Dehesa AS, Quindos PL, Molina EM: Mucocele of the appendix. World J Surg. 2007, 31: 542-548. 10.1007\/s00268-006-0454-1.","journal-title":"World J Surg"},{"key":"746_CR109","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2169\/internalmedicine.46.0079","volume":"46","author":"A Taii","year":"2007","unstructured":"Taii A, Sakagami J, Shinoda M, Taniguchi H, Tosa M, Baba T, Motoyoshi T, Ito R, Mitsufuji S, Kataoka K, Okanoue T: Pseudomyxoma peritonei occurring after an uneventful 23 years interval from appendectomy. Intern Med. 2007, 46: 1109-1112. 10.2169\/internalmedicine.46.0079.","journal-title":"Intern Med"},{"key":"746_CR110","first-page":"705","volume":"59","author":"J Spiliotis","year":"2012","unstructured":"Spiliotis J, Efstathiou E, Halkia E, Vaxevanidou A, Datsis A, Sugarbaker P: The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome. Hepatogastroenterology. 2012, 59: 705-708.","journal-title":"Hepatogastroenterology"},{"key":"746_CR111","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1165\/ajrcmb\/7.6.557","volume":"7","author":"JR Gum Jr","year":"1992","unstructured":"Gum JR: Mucin genes and the proteins they encode: structure, diversity, and regulation. Am J Respir Cell Mol Biol. 1992, 7: 557-564. 10.1165\/ajrcmb\/7.6.557.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"746_CR112","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00010.2005","volume":"86","author":"MC Rose","year":"2006","unstructured":"Rose MC, Voynow JA: Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006, 86: 245-278. 10.1152\/physrev.00010.2005.","journal-title":"Physiol Rev"},{"key":"746_CR113","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1165\/rcmb.2005-0436SF","volume":"34","author":"OW Williams","year":"2006","unstructured":"Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM: Airway mucus: from production to secretion. Am J Respir Cell Mol Biol. 2006, 34: 527-536. 10.1165\/rcmb.2005-0436SF.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"746_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth MA, Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004, 4: 45-60. 10.1038\/nrc1251.","journal-title":"Nat Rev Cancer"},{"key":"746_CR115","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/biof.64","volume":"35","author":"S Rachagani","year":"2009","unstructured":"Rachagani S, Torres MP, Moniaux N, Batra SK: Current status of mucins in the diagnosis and therapy of cancer. Biofactors. 2009, 35: 509-527. 10.1002\/biof.64.","journal-title":"Biofactors"},{"key":"746_CR116","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe DW: Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009, 9: 874-885. 10.1038\/nrc2761.","journal-title":"Nat Rev Cancer"},{"key":"746_CR117","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","volume":"61","author":"RA Cone","year":"2009","unstructured":"Cone RA: Barrier properties of mucus. Adv Drug Deliv Rev. 2009, 61: 75-85. 10.1016\/j.addr.2008.09.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"746_CR118","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1128\/CMR.19.2.315-337.2006","volume":"19","author":"V Lievin-Le Moal","year":"2006","unstructured":"Lievin-Le Moal V, Servin AL: The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev. 2006, 19: 315-337. 10.1128\/CMR.19.2.315-337.2006.","journal-title":"Clin Microbiol Rev"},{"key":"746_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1462-5822.2001.00090.x","volume":"3","author":"VJ McCracken","year":"2001","unstructured":"McCracken VJ, Lorenz RG: The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol. 2001, 3: 1-11. 10.1046\/j.1462-5822.2001.00090.x.","journal-title":"Cell Microbiol"},{"key":"746_CR120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000163037","volume":"1","author":"P Dharmani","year":"2009","unstructured":"Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K: Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun. 2009, 1: 123-135. 10.1159\/000163037.","journal-title":"J Innate Immun"},{"issue":"Suppl 1","key":"746_CR121","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1073\/pnas.1006451107","volume":"108","author":"ME Johansson","year":"2011","unstructured":"Johansson ME, Larsson JM, Hansson GC: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A. 2011, 108 (Suppl 1): 4659-4665.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"746_CR122","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1440-1827.2007.02137.x","volume":"57","author":"AS Mall","year":"2007","unstructured":"Mall AS, Chirwa N, Govender D, Lotz Z, Tyler M, Rodrigues J, Kahn D, Goldberg P: MUC2, MUC5AC and MUC5B in the mucus of a patient with pseudomyxoma peritonei: biochemical and immunohistochemical study. Pathol Int. 2007, 57: 537-547. 10.1111\/j.1440-1827.2007.02137.x.","journal-title":"Pathol Int"},{"key":"746_CR123","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000323137","volume":"5","author":"AS Mall","year":"2011","unstructured":"Mall AS, Lotz Z, Tyler M, Goldberg P, Rodrigues J, Kahn D, Chirwa N, Govender D: Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study. Case Rep Gastroenterol. 2011, 5: 5-16. 10.1159\/000323137.","journal-title":"Case Rep Gastroenterol"},{"key":"746_CR124","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1165\/ajrcmb.13.6.7576713","volume":"13","author":"JK Sheehan","year":"1995","unstructured":"Sheehan JK, Richardson PS, Fung DC, Howard M, Thornton DJ: Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol. 1995, 13: 748-756. 10.1165\/ajrcmb.13.6.7576713.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Pt 2","key":"746_CR125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bj3380507","volume":"338","author":"JK Sheehan","year":"1999","unstructured":"Sheehan JK, Howard M, Richardson PS, Longwill T, Thornton DJ: Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem J. 1999, 338 (Pt 2): 507-513.","journal-title":"Biochem J"},{"key":"746_CR126","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/jso.20038","volume":"86","author":"F Mohamed","year":"2004","unstructured":"Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH: Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol. 2004, 86: 10-15. 10.1002\/jso.20038.","journal-title":"J Surg Oncol"},{"key":"746_CR127","first-page":"67","volume":"70","author":"Z Kinkor","year":"2005","unstructured":"Kinkor Z, Michal M: [Syndrome of pseudomyxoma peritonei\u2013description of three cases and survey of the problem]. Ceska Gynekol. 2005, 70: 67-72.","journal-title":"Ceska Gynekol"},{"key":"746_CR128","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2559.2006.02512.x","volume":"49","author":"D Nonaka","year":"2006","unstructured":"Nonaka D, Kusamura S, Baratti D, Casali P, Younan R, Deraco M: CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology. 2006, 49: 381-387. 10.1111\/j.1365-2559.2006.02512.x.","journal-title":"Histopathology"},{"key":"746_CR129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1525-1438.2007.00988.x","volume":"18","author":"CR Ferreira","year":"2008","unstructured":"Ferreira CR, Carvalho JP, Soares FA, Siqueira SA, Carvalho FM: Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer. 2008, 18: 59-65.","journal-title":"Int J Gynecol Cancer"},{"key":"746_CR130","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000332739","volume":"79","author":"MS Chang","year":"2012","unstructured":"Chang MS, Byeon SJ, Yoon SO, Kim BH, Lee HS, Kang GH, Kim WH, Park KJ: Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms. Pathobiology. 2012, 79: 45-53. 10.1159\/000332739.","journal-title":"Pathobiology"},{"key":"746_CR131","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1073\/pnas.95.10.5718","volume":"95","author":"JD Li","year":"1998","unstructured":"Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C: Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A. 1998, 95: 5718-5723. 10.1073\/pnas.95.10.5718.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"746_CR132","doi-asserted-by":"publisher","first-page":"32258","DOI":"10.1074\/jbc.M204862200","volume":"277","author":"M Perrais","year":"2002","unstructured":"Perrais M, Pigny P, Copin MC, Aubert JP, Van Seuningen I: Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor\/Ras\/Raf\/extracellular signal-regulated kinase cascade and Sp1. J Biol Chem. 2002, 277: 32258-32267. 10.1074\/jbc.M204862200.","journal-title":"J Biol Chem"},{"key":"746_CR133","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","volume":"8","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski RZ, Baldwin AS: NF-kappaB as a therapeutic target in cancer. Trends Mol Med. 2002, 8: 385-389. 10.1016\/S1471-4914(02)02375-4.","journal-title":"Trends Mol Med"},{"key":"746_CR134","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jso.23146","volume":"106","author":"HA Choudry","year":"2012","unstructured":"Choudry HA, O\u2019Malley ME, Guo ZS, Zeh HJ, Bartlett DL: Mucin as a therapeutic target in pseudomyxoma peritonei. J Surg Oncol. 2012, 106: 911-917. 10.1002\/jso.23146.","journal-title":"J Surg Oncol"},{"key":"746_CR135","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s000110050576","volume":"49","author":"ML Enss","year":"2000","unstructured":"Enss ML, Cornberg M, Wagner S, Gebert A, Henrichs M, Eisenblatter R, Beil W, Kownatzki R, Hedrich HJ: Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res. 2000, 49: 162-169. 10.1007\/s000110050576.","journal-title":"Inflamm Res"},{"key":"746_CR136","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1006\/bbrc.2000.3107","volume":"274","author":"YD Kim","year":"2000","unstructured":"Kim YD, Kwon EJ, Kwon TK, Baek SH, Song SY, Suh JS: Regulation of IL-1beta-mediated MUC2 gene in NCI-H292 human airway epithelial cells. Biochem Biophys Res Commun. 2000, 274: 112-116. 10.1006\/bbrc.2000.3107.","journal-title":"Biochem Biophys Res Commun"},{"key":"746_CR137","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1440-1711.2003.t01-1-01163.x","volume":"81","author":"J Iwashita","year":"2003","unstructured":"Iwashita J, Sato Y, Sugaya H, Takahashi N, Sasaki H, Abe T: mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol. 2003, 81: 275-282. 10.1046\/j.1440-1711.2003.t01-1-01163.x.","journal-title":"Immunol Cell Biol"},{"key":"746_CR138","first-page":"L484","volume":"271","author":"H Kai","year":"1996","unstructured":"Kai H, Yoshitake K, Hisatsune A, Kido T, Isohama Y, Takahama K, Miyata T: Dexamethasone suppresses mucus production and MUC-2 and MUC-5\u00a0AC gene expression by NCI-H292 cells. Am J Physiol. 1996, 271: L484-L488.","journal-title":"Am J Physiol"},{"key":"746_CR139","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbaexp.2004.09.004","volume":"1680","author":"OJ Schoneveld","year":"2004","unstructured":"Schoneveld OJ, Gaemers IC, Lamers WH: Mechanisms of glucocorticoid signalling. Biochim Biophys Acta. 2004, 1680: 114-128. 10.1016\/j.bbaexp.2004.09.004.","journal-title":"Biochim Biophys Acta"},{"key":"746_CR140","first-page":"765","volume":"36","author":"K Okudaira","year":"2010","unstructured":"Okudaira K, Kakar S, Cun L, Choi E, Wu Decamillis R, Miura S, Sleisenger MH, Kim YS, Deng G: MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int J Oncol. 2010, 36: 765-775.","journal-title":"Int J Oncol"},{"key":"746_CR141","first-page":"570","volume":"61","author":"F Aslam","year":"2001","unstructured":"Aslam F, Palumbo L, Augenlicht LH, Velcich A: The Sp family of transcription factors in the regulation of the human and mouse MUC2 gene promoters. Cancer Res. 2001, 61: 570-576.","journal-title":"Cancer Res"},{"key":"746_CR142","first-page":"4051","volume":"29","author":"TC Chua","year":"2009","unstructured":"Chua TC, Akther J, Yao P, Morris DL: In vivo model of pseudomyxoma peritonei for novel candidate drug discovery. Anticancer Res. 2009, 29: 4051-4055.","journal-title":"Anticancer Res"},{"key":"746_CR143","first-page":"105","volume":"28","author":"J Akhter","year":"2008","unstructured":"Akhter J, Yao P, Johnson LA, Riordan SM, Morris DL: A new peritoneal carcinomatosis model in cyclosporine immunosuppressed rats. Anticancer Res. 2008, 28: 105-108.","journal-title":"Anticancer Res"},{"key":"746_CR144","unstructured":"Bromelain. Monograph. Altern Med Rev. 2010, 15: 361-368."},{"key":"746_CR145","doi-asserted-by":"crossref","unstructured":"N-acetylcysteine. Altern Med Rev. 2000, 5: 467-471.","DOI":"10.1046\/j.1365-3156.2000.00596.x"},{"key":"746_CR146","first-page":"403","volume":"2013","author":"A Amini","year":"2013","unstructured":"Amini A, Ehteda A, Masoumi Moghaddam S, Akhter J, Pillai K, Morris DL: Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21). Onco Targets Ther. 2013, 2013: 403-409.","journal-title":"Onco Targets Ther"},{"key":"746_CR147","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/07357907.2013.784777","volume":"31","author":"K Pillai","year":"2013","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL: Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma. Cancer Invest. 2013, 31: 241-250. 10.3109\/07357907.2013.784777.","journal-title":"Cancer Invest"},{"key":"746_CR148","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/CAD.0000000000000039","volume":"25","author":"K Pillai","year":"2014","unstructured":"Pillai K, Ehteda A, Akhter J, Chua TC, Morris DL: Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. Anti-cancer drugs. 2014, 25: 150-160. 10.1097\/CAD.0000000000000039.","journal-title":"Anti-cancer drugs"},{"key":"746_CR149","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.28380","volume":"134","author":"K Pillai","year":"2014","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL: A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei. Int J Cancer. 2014, 134: 478-486. 10.1002\/ijc.28380.","journal-title":"Int J Cancer"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-9-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:47:17Z","timestamp":1630554437000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,5]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-9-71","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,5]]},"assertion":[{"value":"28 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}